Related Experiment Video
Updated: May 3, 2026

A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor
Published on: June 27, 2011
Cloning and expression of recombinant human GMCSF from Pichia pastoris GS115--a progressive strategy for economic
K Srinivasa Babu1, Krishna Kanth Pulicherla, Aju Antony
11Centre for Biotechnology, Anna University, Chennai, India; and 2Centre for Bioseparation Technology, VIT University, Vellore, India.
Abstract:
Human granulocyte-macrophage colony-stimulating factor (hGMCSF) is a proinflammatory cytokine and hematopoietic growth factor. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGMCSF) serves as a biotherapeutic agent in bone marrow stimulations, vaccine development, gene therapy approaches, and stem cell mobilization. The objective of the present study includes construction of rhGMCSF having N-terminal intein tag, expression of protein both extracellularly and intracellularly from yeast expression system followed by its purification in a single step by affinity chromatography. The soluble and biologically active rhGMCSF was obtained from Pichia pastoris GS115. About 122 g DCW/L of final yield was obtained for both cytosolic and secretory expression of Pichia GS115 strain. Purified intracellular hGMCSF was 420 mg/L with a specific activity of 2.1×10⁸ IU/mg, and the purified extracellular recombinant protein was 360 mg/L with a specific activity of 1.9×10⁸ IU/mg. The data presented here indicate the possibilities of exploring the economic ways of producing the rhGMCSF.
Related Concept Videos
Upstream Processing
Bioreactor Controls-III

